EUVIMEDAvasta EUVIMED
Crossref

Fusion with type 2 macrophages induces melanoma cell heterogeneity that potentiates immunological escape from cytotoxic T lymphocytes

Tomoyuki Minowa, Yoshihiko Hirohashi iD, Kenji Murata, Kenta Sasaki, Toshiya Handa, Munehide Nakatsugawa, Yuka Mizue, Aiko Murai, Terufumi Kubo, Takayuki Kanaseki, Tomohide Tsukahara, Sadahiro Iwabuchi and 4 more

The Journal of Pathology · 2023-07 · 260 (3) · 304-316

DOI: 10.1002/path.6083 ↗

At a glance

Journal article in The Journal of Pathology, published online on 2023-05-03. Written by Tomoyuki Minowa and 15 co-authors. Institution: Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan. Major MEDLINE topics: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Melanoma. Cited 15 times so far (Crossref); 50 references. Funded by: Japan Agency for Medical Research and Development, Japan Science and Technology Agency, Japan Society for the Promotion of Science.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

Evasion from immunity is a major obstacle to the achievement of successful cancer immunotherapy. Hybrids derived from cell–cell fusion are theoretically associated with tumor heterogeneity and progression by conferring novel properties on tumor cells, including drug resistance and metastatic capacity; however, their impact on immune evasion remains unknown. Here, we investigated the potency of tumor–macrophage hybrids in immune evasion. Hybrids were established by co‐culture of a melanoma cell line (A375 cells) and type 2 macrophages. The hybrids showed greater migration ability and greater tumorigenicity than the parental melanoma cells. The hybrids showed heterogeneous sensitivity to New York esophageal squamous cell carcinoma‐1 (NY‐ESO‐1)‐specific T‐cell receptor‐transduced T (TCR‐T) cells and two out of four hybrid clones showed less sensitivity to TCR‐T compared with the parental cells. An in vitro tumor heterogeneity model revealed that the TCR‐T cells preferentially killed the parental cells compared with the hybrids and the survival rate of the hybrids was higher than that of the parental cells, indicating that the hybrids evade killing by TCR‐T cells efficiently. Analysis of a single‐cell RNA sequencing dataset of patients with melanoma revealed that a few macrophages expressed RNA encoding melanoma differentiation antigens including melan A, tyrosinase, and premelanosome protein, which indicated the presence of hybrids in primary melanoma. In addition, the number of potential hybrids was correlated with a poorer response to immune checkpoint blockade. These results provide evidence that melanoma–macrophage fusion has a role in tumor heterogeneity and immune evasion. © 2023 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaMelanomaHumansT-Lymphocytes, CytotoxicMacrophagesReceptors, Antigen, T-CellAntigens, Neoplasm

Author keywords

cell fusioncytotoxic T lymphocyteshybrid cellsimmunological escapemelanoma

Substances

Receptors, Antigen, T-CellAntigens, Neoplasm

Authors and institutions

  • Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Dermatology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
  • Department of Pathology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan.
  • Department of Molecular Pathophysiology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan.

ORCID profiles: Yoshihiko Hirohashi

Funding

  • Japan Agency for Medical Research and Development
  • Japan Science and Technology Agency
  • Japan Society for the Promotion of Science

Cite

APA

Minowa, T., Hirohashi, Y., Murata, K., Sasaki, K., Handa, T., Nakatsugawa, M., Mizue, Y., Murai, A., Kubo, T., Kanaseki, T., Tsukahara, T., Iwabuchi, S., Hashimoto, S., Ishida-Yamamoto, A., Uhara, H., & Torigoe, T. (2023). Fusion with type 2 macrophages induces melanoma cell heterogeneity that potentiates immunological escape from cytotoxic T lymphocytes. The Journal of Pathology, 260(3), 304-316. https://doi.org/10.1002/path.6083

Vancouver

Minowa T, Hirohashi Y, Murata K, Sasaki K, Handa T, Nakatsugawa M, et al. Fusion with type 2 macrophages induces melanoma cell heterogeneity that potentiates immunological escape from cytotoxic T lymphocytes. The Journal of Pathology. 2023;260(3):304-316. doi:10.1002/path.6083

BibTeX
@article{Minowa2023,
  author = {Minowa, Tomoyuki and Hirohashi, Yoshihiko and Murata, Kenji and Sasaki, Kenta and Handa, Toshiya and Nakatsugawa, Munehide and Mizue, Yuka and Murai, Aiko and Kubo, Terufumi and Kanaseki, Takayuki and Tsukahara, Tomohide and Iwabuchi, Sadahiro and Hashimoto, Shinichi and Ishida-Yamamoto, Akemi and Uhara, Hisashi and Torigoe, Toshihiko},
  title = {Fusion with type 2 macrophages induces melanoma cell heterogeneity that potentiates immunological escape from cytotoxic T lymphocytes},
  journal = {The Journal of Pathology},
  year = {2023},
  volume = {260},
  number = {3},
  pages = {304--316},
  doi = {10.1002/path.6083}
}
Start for free →